<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jiang H</submitter><funding>Key project of Science and Technology Department of Liaoning Province</funding><pagination>e063082</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9680142</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(11)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>To develop and evaluate a psychosocial adaptation (PSA) questionnaire of women with breast cancer treated with adjuvant endocrine therapy (AET).&lt;h4>Design&lt;/h4>Cross-sectional study.&lt;h4>Setting&lt;/h4>Conducted study in a tertiary care centre in China from March to June 2021.&lt;h4>Participants&lt;/h4>Women with breast cancer who have received AET.&lt;h4>Methods&lt;/h4>Item development and extraction were based on literature, qualitative interviews (n=16) and assessment of content validity. 300 participants were recruited to perform item analysis, internal consistency reliability and exploratory factor analysis by cross-sectional studies. Finally, test-retest, criterion validity and confirmatory factor analysis of the questionnaire were performed with 96 respondents.&lt;h4>Results&lt;/h4>An initial questionnaire was devised. The exploratory factor analysis demonstrated four factors: emotional response (six items), self-worth (five items), physical impacts (three items) and social communication (two items). The cumulative contribution of the factors was 65.057%. Cronbach's alpha coefficient of the questionnaire was 0.876. The correlation coefficient between the questionnaire and General Self-Efficacy Scale was 0.565 (p&lt;0.01). A 16-item questionnaire and its factorial structure were confirmed.&lt;h4>Conclusions&lt;/h4>The 16-item questionnaire had good reliability and validity. This could be a useful tool to assess the PSA levels among women with breast cancer treated with AET and provide a basis for further research.</pubmed_abstract><journal>BMJ open</journal><pubmed_title>Development and evaluation of a psychosocial adaptation questionnaire for women with breast cancer treated with adjuvant endocrine therapy: a single-centre, cross-sectional study in China.</pubmed_title><pmcid>PMC9680142</pmcid><funding_grant_id>2008225010-3</funding_grant_id><pubmed_authors>Jin F</pubmed_authors><pubmed_authors>Dong Y</pubmed_authors><pubmed_authors>Jiang H</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Xu H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Development and evaluation of a psychosocial adaptation questionnaire for women with breast cancer treated with adjuvant endocrine therapy: a single-centre, cross-sectional study in China.</name><description>&lt;h4>Objective&lt;/h4>To develop and evaluate a psychosocial adaptation (PSA) questionnaire of women with breast cancer treated with adjuvant endocrine therapy (AET).&lt;h4>Design&lt;/h4>Cross-sectional study.&lt;h4>Setting&lt;/h4>Conducted study in a tertiary care centre in China from March to June 2021.&lt;h4>Participants&lt;/h4>Women with breast cancer who have received AET.&lt;h4>Methods&lt;/h4>Item development and extraction were based on literature, qualitative interviews (n=16) and assessment of content validity. 300 participants were recruited to perform item analysis, internal consistency reliability and exploratory factor analysis by cross-sectional studies. Finally, test-retest, criterion validity and confirmatory factor analysis of the questionnaire were performed with 96 respondents.&lt;h4>Results&lt;/h4>An initial questionnaire was devised. The exploratory factor analysis demonstrated four factors: emotional response (six items), self-worth (five items), physical impacts (three items) and social communication (two items). The cumulative contribution of the factors was 65.057%. Cronbach's alpha coefficient of the questionnaire was 0.876. The correlation coefficient between the questionnaire and General Self-Efficacy Scale was 0.565 (p&lt;0.01). A 16-item questionnaire and its factorial structure were confirmed.&lt;h4>Conclusions&lt;/h4>The 16-item questionnaire had good reliability and validity. This could be a useful tool to assess the PSA levels among women with breast cancer treated with AET and provide a basis for further research.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-06-01T02:48:33.903Z</modification><creation>2025-06-01T02:48:33.903Z</creation></dates><accession>S-EPMC9680142</accession><cross_references><pubmed>36410798</pubmed><doi>10.1136/bmjopen-2022-063082</doi></cross_references></HashMap>